TVM Capital Life Science Email Format
Venture Capital and Private Equity PrincipalsBavaria, Germany11-50 Employees
TVM Capital Life Science is an international venture capital firm based at 4 Ottostr. München, Bavaria 80333 Germany, focused on investments in life science innovations. The firm maintains a transatlantic investment team and manages approximately $900 million in assets. TVM's portfolio targets therapeutics and medical technologies from North America and the EU that are differentiated first-in-class or best-in-class assets with the potential to transform standard of care. The firm pursues a two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach called Project-Focused Company (PFC), leveraging its relationship with Eli Lilly and Company, and also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics. The investment team has collaborated for over a decade to implement the firm's investment approach. The firm employs between 11 and 50 people.